Home > Insider Trading > Filing (0001131096-18-000084)

Filing Details

Accession Number:: 0001131096-18-000084
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-05 17:49:18
Reporting Period:: 2018-03-01

Accepted Time:: 2018-03-05 17:49:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1131096	Athenahealth Inc	ATHN	Services-Business Services, Nec (7389)	043387530

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1662445	John Timothy O'brien	C/O Athenahealth, Inc. 311 Arsenal St. Watertown MA 02472	Svp, Chief Marketing Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-03-01	285	$0.00	11,320	No	4	A	Direct
Common Stock	Disposition	2018-03-01	84	$139.74	11,236	No	4	F	Direct
Common Stock	Acquisiton	2018-03-01	745	$0.00	11,981	No	4	A	Direct
Common Stock	Disposition	2018-03-01	220	$139.74	11,761	No	4	F	Direct
Common Stock	Disposition	2018-03-01	66	$139.74	11,695	No	4	F	Direct
Common Stock	Disposition	2018-03-01	148	$139.74	11,547	No	4	F	Direct
Common Stock	Disposition	2018-03-01	63	$139.74	11,484	No	4	F	Direct
Common Stock	Disposition	2018-03-01	921	$139.74	10,563	No	4	F	Direct
Common Stock	Acquisiton	2018-03-01	1,500	$0.00	12,063	No	4	A	Direct
Common Stock	Disposition	2018-03-02	164	$136.00	11,899	No	4	S	Direct
Common Stock	Disposition	2018-03-02	1,100	$136.92	10,799	No	4	S	Direct
Common Stock	Disposition	2018-03-02	1,800	$137.60	8,999	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	F	Direct
No	4	A	Direct
No	4	F	Direct
No	4	F	Direct
No	4	F	Direct
No	4	F	Direct
No	4	F	Direct
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2018-03-01	3,690	$0.00	3,690	$137.49

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,690	2019-03-01	2028-03-01	No	4	A	Direct

Footnotes

On March 1, 2016, the Reporting Person was granted a Performance Stock Unit ("PSU") award of 2,719 PSUs. The PSUs convert into common stock on a one-for-one basis, and vest in three equal annual installments beginning on March 1, 2017 based on the Issuer's satisfaction of certain performance criteria for the fiscal years ending December 31, 2016, 2017 and 2018. On February 6, 2018, the Compensation Committee of the Board of Directors of the Issuer certified that certain performance criteria for 2017 was met, resulting in vesting of PSUs as to 285 shares on March 1, 2018.
On March 1, 2017, the Reporting Person was granted an award of 6,686 PSUs. The PSUs convert into common stock on a one-for-one basis, and vest in three equal annual installments beginning on March 1, 2018 based on the Issuer's satisfaction of certain performance criteria for the fiscal years ending December 31, 2017, 2018 and 2019. On February 6, 2018, the Compensation Committee of the Board of Directors of the Issuer certified that certain performance criteria for 2017 was met, resulting in vesting of PSUs as to 745 shares on March 1, 2018.
Represents a restricted stock unit ("RSU") award granted under the Issuer's 2007 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The award is subject to time-based vesting and vests in three equal annual installments beginning on March 1, 2019. The RSUs will be settled only in stock.
The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 13, 2017, in accordance with Rule 10b5-1.
Represents a weighted average price. These shares were purchased by the Reporting Person in multiple transactions at prices ranging from $136.46 to $137.19, inclusive.
Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $137.27 to $138.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (5) and (6).
Includes 6,974 units of common stock that were granted pursuant to RSU awards under the athenahealth, Inc. 2007 Stock Option and Incentive Plan, as amended and restated. The RSUs are subject to time-based vesting and will be settled only in stock.
The option award vests in three equal annual installments beginning on March 1, 2019.